0001576280-21-000108.txt : 20211123
0001576280-21-000108.hdr.sgml : 20211123
20211123190702
ACCESSION NUMBER: 0001576280-21-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211119
FILED AS OF DATE: 20211123
DATE AS OF CHANGE: 20211123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Talasaz AmirAli
CENTRAL INDEX KEY: 0001753159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 211440598
MAIL ADDRESS:
STREET 1: 18 ISABELLA AVENUE
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
wf-form4_163771240170350.xml
FORM 4
X0306
4
2021-11-19
0
0001576280
Guardant Health, Inc.
GH
0001753159
Talasaz AmirAli
505 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
Co-Chief Executive Officer
COMMON STOCK
2021-11-19
4
P
0
37721
97.8225
A
1787066
D
COMMON STOCK
2021-11-19
4
P
0
12279
98.7848
A
1799345
D
COMMON STOCK
2021-11-23
4
P
0
6033
92.4199
A
1805378
D
COMMON STOCK
2021-11-23
4
P
0
23467
93.0514
A
1828845
D
COMMON STOCK
2021-11-23
4
P
0
5000
94
A
1833845
D
COMMON STOCK
2021-11-23
4
P
0
5000
95.50
A
1838845
D
COMMON STOCK
2021-11-23
4
P
0
14900
96.8305
A
1853745
D
COMMON STOCK
2021-11-23
4
P
0
100
98
A
1853845
D
COMMON STOCK
470800
I
Shares held by Talasaz Investments, L.P.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $97.64 to $98.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $98.75 to $99.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.885 to $92.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $92.915 to $93.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $96.50 to $97.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ John Saia, as attorney-in-fact for AmirAli Talasaz
2021-11-23